fulgentgenetics.com (FLGT) Cash Funds per Single Share

Corporate emblem and logo of Fulgent (FLGT)

Fulgent Genetics, Inc. (FLGT) relies on US domestic demand while remaining sensitive to reagent supply chain disruptions. The development of AI algorithms and spatial biology is driving R&D. The cash per share on the GURU.Markets service time chart shows that the current value is 10.50. Liquidity is maintained through close cooperation with government laboratories and clinics.

FLGT: Fulgent Genetics Inc Cash per Single Share 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Fulgent (FLGT)

- market price and analyst price targets:
- cash position and cash flow details:
Comprehensive company analysis:Fulgent Corp FLGT
Mass-produced product of Fulgent Corp

For Fulgent Genetics, Inc. (FLGT), with its focus on NGS sequencing and oncology diagnostics, the cash per share analysis confirms a significant reserve for M&A transactions amounting to 10.50. This metric objectively measures the equity value of liquidity, allowing for the immediate identification of cash gaps and an assessment of the business's real margin of safety in the event of a potential decline in operating profit.